Comerica Bank’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$5.69M Sell
23,615
-2,038
-8% -$521K 0.02% 547
2025
Q3
$7.02M Sell
25,653
-1,226
-5% -$335K 0.03% 545
2025
Q2
$6.93M Sell
26,879
-1,245
-4% -$297K 0.03% 555
2025
Q1
$6.3M Sell
28,124
-306
-1% -$71.4K 0.03% 572
2024
Q4
$6.5M Buy
28,430
+253
+0.9% +$60.9K 0.03% 574
2024
Q3
$6.88M Sell
28,177
-368
-1% -$82.2K 0.03% 551
2024
Q2
$5.46M Sell
28,545
-600
-2% -$122K 0.02% 630
2024
Q1
$5.77M Sell
29,145
-935
-3% -$171K 0.02% 634
2023
Q4
$5.17M Buy
30,080
+331
+1% +$50.9K 0.02% 665
2023
Q3
$4.4M Buy
29,749
+21,082
+243% +$3.81M 0.02% 683
2023
Q2
$9 Buy
+8,667
New +$1.93M ﹤0.01% 385
2022
Q4
$6.54M Sell
28,999
-973
-3% -$214K 0.05% 449
2022
Q3
$6.76M Sell
29,972
-283
-0.9% -$64.4K 0.06% 369
2022
Q2
$6.8M Sell
30,255
-289
-0.9% -$61.5K 0.06% 388
2022
Q1
$7.48M Sell
30,544
-174
-0.6% -$42.1K 0.05% 397
2021
Q4
$7.13M Sell
30,718
-4,980
-14% -$1.29M 0.05% 399
2021
Q3
$9.55M Sell
35,698
-6,663
-16% -$1.82M 0.06% 360
2021
Q2
$12M Sell
42,361
-1,370
-3% -$288K 0.07% 270
2021
Q1
$9.15M Sell
43,731
-1,759
-4% -$353K 0.05% 391
2020
Q4
$9.8M Sell
45,490
-184
-0.4% -$36.7K 0.06% 340
2020
Q3
$8.36M Sell
45,674
-682
-1% -$126K 0.06% 341
2020
Q2
$9.52M Buy
46,356
+1,147
+3% +$188K 0.07% 261
2020
Q1
$7.28M Sell
45,209
-1,212
-3% -$193K 0.07% 301
2019
Q4
$7.68M Buy
46,421
+2,855
+7% +$411K 0.06% 351
2019
Q3
$5.56M Sell
43,566
-489
-1% -$64.1K 0.04% 459
2019
Q2
$5.45M Buy
44,055
+1,387
+3% +$154K 0.04% 465
2019
Q1
$4.34M Buy
42,668
+2,539
+6% +$262K 0.04% 590
2018
Q4
$3.69M Sell
40,129
-4,985
-11% -$534K 0.03% 678
2018
Q3
$4.54M Sell
45,114
-9,098
-17% -$997K 0.04% 567
2018
Q2
$5.93M Sell
54,212
-808
-1% -$81.8K 0.04% 515
2018
Q1
$5.52M Sell
55,020
-1,009
-2% -$95.3K 0.04% 551
2017
Q4
$5.62M Buy
56,029
+6,423
+13% +$531K 0.04% 572
2017
Q3
$4.12M Sell
49,606
-75,948
-60% -$5.81M 0.03% 731
2017
Q2
$9.69M Buy
125,554
+854
+0.7% +$61.1K 0.07% 283
2017
Q1
$9.08M Buy
124,700
+5,093
+4% +$352K 0.07% 301
2016
Q4
$7.81M Buy
119,607
+3,565
+3% +$218K 0.06% 333
2016
Q3
$7.49M Sell
116,042
-165
-0.1% -$11K 0.06% 319
2016
Q2
$8.21M Buy
116,207
+2,515
+2% +$148K 0.07% 283
2016
Q1
$6.79M Sell
113,692
-2,321
-2% -$131K 0.06% 323
2015
Q4
$6.05M Sell
116,013
-716
-0.6% -$40.4K 0.06% 335
2015
Q3
$5.95M Sell
116,729
-116,397
-50% -$6.27M 0.06% 357
2015
Q2
$13.1M Buy
233,126
+116,436
+100% +$7.35M 0.06% 347
2015
Q1
$8.38M Sell
116,690
-126,108
-52% -$8.19M 0.07% 285
2014
Q4
$13.6M Buy
242,798
+117,643
+94% +$6.14M 0.06% 332
2014
Q3
$6.17M Buy
125,155
+1,195
+1% +$60.9K 0.05% 359
2014
Q2
$6.28M Sell
123,960
-11,288
-8% -$559K 0.05% 371
2014
Q1
$6.04M Buy
135,248
+1,137
+0.8% +$51.1K 0.05% 440
2013
Q4
$6.31M Sell
134,111
-2,922
-2% -$148K 0.05% 405
2013
Q3
$7.24M Buy
137,033
+9,114
+7% +$442K 0.05% 388
2013
Q2
$5.77M Buy
+127,919
New +$6.07M 0.05% 406

Other funds holding RMD

Comerica Bank's RMD Position: Q4 2025 in Review

Comerica Bank reduced its ResMed (RMD) stake by 7.9% in Q4 2025, selling an estimated $521K and leaving 23,615 shares worth $5.69M. The position accounts for 0.02% of the portfolio, ranked #547.

Comerica Bank first reported a position in RMD in Q2 2013 and has held it in 50 quarters since. The position peaked at $13.6M in Q4 2014. 946 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Comerica Bank held 23,615 shares of ResMed worth $5.69M as of Q4 2025.
  • Comerica Bank sold 2,038 ResMed shares in Q4 2025, an estimated $521K.
  • ResMed made up 0.02% of Comerica Bank's portfolio in Q4 2025, its #547 holding.
  • Comerica Bank first reported a position in ResMed in Q2 2013 and has held it in 50 quarters since.
  • Comerica Bank's ResMed position peaked at $13.6M in Q4 2014.
  • 946 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.